HomeAI · summaries
Storia in 4 fonti
Does Revolution Medicines' pancreatic cancer drug have even greater potential?
Revolution Medicines' pancreatic cancer drug has not yet been approved — and already talk has shifted to how (and when) its use might be expanded.
Confronto fonti
4 prospettive sulla stessa storiaTimeline cronologica
- ·
hindustantimes.com
Revolution Medicines' new cancer pill extends life: ‘Molecular glue’ works, study shows
While the drug is not a cure, researchers say it could meaningfully improve both the length and quality of life for patients with advanced disease. | World News
- ·
pharmaceutical-technology.com
ASCO26: RevMed’s daraxonrasib presents a turning point for pancreatic cancer - Pharmaceutical Technology
The field is ecstatic about the prospect of a targeted therapy meaningfully extending overall survival in pancreatic cancer.
